These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6450073)

  • 1. Modification by anionic polysaccharides of the antithrombin III inhibition of plasmin.
    Kindness G; Williamson FB; Long WF
    Biochem Soc Trans; 1980 Oct; 8(5):652-3. PubMed ID: 6450073
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetic analysis of the heparin-enhanced plasmin--antithrombin III reaction. Apparent catalytic role of heparin.
    Machovich R; Bauer PI; Arányi P; Kecskés E; Büki KG; Horváth I
    Biochem J; 1981 Dec; 199(3):521-6. PubMed ID: 6462134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GAGs-potentiated inhibition of thrombin, factor Xa and plasmin in plasma and in a purified system containing antithrombin III - correlation with total charge density.
    Cofrancesco E; Vigo A; Pogliani EM
    Thromb Haemost; 1981 Dec; 46(4):749-51. PubMed ID: 6460339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition of human plasmin by human antithrombin-heparin cofactor.
    Highsmith RF; Rosenberg RD
    J Biol Chem; 1974 Jul; 249(14):4335-8. PubMed ID: 4276455
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of thrombin by antithrombin III in the presence of certain glycosaminoglycans found in the mammalian aorta.
    Hatton MW; Berry LR; Regoeczi E
    Thromb Res; 1978 Oct; 13(4):655-70. PubMed ID: 570737
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of heparin on factor XIa and plasmin.
    Rosenberg RD
    Thromb Diath Haemorrh; 1975 Feb; 33(1):51-62. PubMed ID: 235160
    [No Abstract]   [Full Text] [Related]  

  • 7. Modulations of thrombin activity by polyelectrolytes in the presence of antithrombin III.
    Schiele J; Heuck CC
    Semin Thromb Hemost; 1991; 17 Suppl 1():35-41. PubMed ID: 2068569
    [No Abstract]   [Full Text] [Related]  

  • 8. [The antithrombin action of stichopus japonicus acid mucopolysaccharide (Sjamp) is mediated by heparin cofactor II].
    Zhang G
    Zhonghua Xue Ye Xue Za Zhi; 1997 Mar; 18(3):126-9. PubMed ID: 15622771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of thrombin and plasmin to heparin and antithrombin III.
    Bauer PI; Breuer Z; Machovich R; Büki KG; Horváth I
    Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):155-61. PubMed ID: 2944348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by heparin-modulated antithrombin III of amidolysis catalysed by m beta-acrosin.
    Long WF; Williamson FB
    Biochem J; 1984 Feb; 217(3):721-5. PubMed ID: 6231919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
    Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
    Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluations of antithrombin III and alpha 2-plasmin inhibitor assay method with chromogenic substrates (S-2238, S-2251 (author's transl)].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1981 Feb; 29(2):179-82. PubMed ID: 6453246
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of thrombin, plasmin, thrombin-antithrombin III complex and plasmin-antithrombin III complex with isolated hepatocytes.
    Spolarics Z; Kalapos MP; Léránt I; Garzó T; Antoni F; Mandl J; Machovich R
    Biochim Biophys Acta; 1989 Aug; 1012(3):231-6. PubMed ID: 2547438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of plasmin, thrombin, and antithrombin III as etiological factors in delayed cerebral vasospasm.
    White RP; Robertson JT
    Neurosurgery; 1985 Jan; 16(1):27-35. PubMed ID: 2579347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
    Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
    Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
    Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
    Scully MF; Ellis V; Seno N; Kakkar VV
    Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of heparin in the interaction of serine proteinases with antithrombin III.
    Stürzebecher J
    Acta Biol Med Ger; 1977; 36(11-12):1893-7. PubMed ID: 151469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of plasmin by antithrombin-heparin complex. II. During thrombolytic therapy in man.
    Collen D; Semeraro N; Telesforo P; Verstraete M
    Br J Haematol; 1978 May; 39(1):101-10. PubMed ID: 149555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemistry of the hemostatic mechanism and its relationship to the action of heparin.
    Rosenberg RD
    Fed Proc; 1977 Jan; 36(1):10-8. PubMed ID: 63388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.